Data updated: Mar 10, 2026
NYSTATIN AND TRIAMCINOLONE ACETONIDE
NYSTATIN
Approved 1985-10-08
25
Indications
--
Phase 3 Trials
40
Years on Market
Details
- Status
- Discontinued
- First Approved
- 1985-10-08
- Routes
- TOPICAL
- Dosage Forms
- OINTMENT, CREAM
Companies
CHARTWELL RX AMNEAL SUN PHARMA CANADA ALPHARMA US PHARMS ALEMBIC RISING Lupin MACLEODS PHARMS LTD PERRIGO NEW YORK PHARMAFAIR GLENMARK PHARMS LTD Dr. Reddy's PAI HOLDINGS PHARM STRIDES PHARMA FOUGERA PHARMS INC ZYDUS LIFESCIENCES EPIC PHARMA LLC PADAGIS ISRAEL CROWN LABS INC TORRENT
Website: ↗
NYSTATIN AND TRIAMCINOLONE ACETONIDE Approval History
Loading approval history...
What NYSTATIN AND TRIAMCINOLONE ACETONIDE Treats
25 FDA approvalsOriginally approved for its first indication in 1985 . Covers 25 distinct patient populations.
- Other (25)
Other
(25 approvals)- • Approved indication (Oct 1985)
- • Approved indication (Oct 1985)
- • Approved indication (Mar 1987)
- • Approved indication (Dec 1987)
- • Approved indication (Mar 1993)
- • Approved indication (Jun 2016)
- • Approved indication (Oct 2016)
- • Approved indication (Oct 2016)
- • Approved indication (Dec 2016)
- • Approved indication (Dec 2016)
- • Approved indication (Dec 2016)
- • Approved indication (Jan 2017)
- • Approved indication (Aug 2017)
- • Approved indication (Aug 2017)
- • Approved indication (Dec 2017)
- • Approved indication (Jan 2018)Letter
- • Approved indication (Feb 2018)
- • Approved indication (May 2018)
- • Approved indication (Nov 2018)
- • Approved indication (Nov 2019)
- • Approved indication (Jul 2020)
- • Approved indication (Mar 2021)
- • Approved indication (Aug 2021)
- • Approved indication (Mar 2022)
- • Approved indication (Jul 2022)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
NYSTATIN AND TRIAMCINOLONE ACETONIDE FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.